IGC Pharma (IGC) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
IGC Pharma (IGC) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, losing 33.4% versus a loss of 44.4%. MIRA Pharmaceuticals is the larger company by market cap ($31.3 million vs $28.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IGC | MIRA |
|---|---|---|
| Share price | $0.2799 | $0.7455 |
| Market cap | $28.94M | $31.33M |
| 1-day change | -1.75% | +6.05% |
| YTD return | -0.04% | -50.63% |
| 1-year return | -33.36% | -44.37% |
| 5-year return | -80.83% | — |
| EPS (TTM) | $-0.07 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.45 | $2.45 |
| 52-week low | $0.24 | $0.60 |
| Distance from 52-week high | -37.80% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +2043.62% | +369.48% |
| Average volume | 708.76K | 585.75K |
| Shares outstanding | 103.38M | 42.02M |
| Employees | 70 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IGC has outperformed MIRA by 11.0 percentage points over the past year.
About IGC Pharma
IGC stock →IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's.
Health Care · Biotechnology: Pharmaceutical Preparations · 70 employees
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
IGC vs MIRA FAQ
Which is bigger, IGC Pharma or MIRA Pharmaceuticals?
MIRA Pharmaceuticals (MIRA) is larger, with a market capitalization of $31.33M compared with $28.94M for IGC Pharma (IGC).
Which stock has performed better over the past year, IGC or MIRA?
IGC returned -33.36% over the past 12 months, compared with -44.37% for MIRA (price return, excluding dividends). Past performance does not predict future results.
Are IGC Pharma and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.